WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Related articles:
Related suggestion:
58 killed by 2 weeks of floods in TanzaniaXi to Attend G20 Summit, APEC Economic Leaders' Meeting and Visit ThailandCity Helps Women Find Jobs Near HomeChina's used vehicle sales up in first 2 monthsXi Focus: Xi Calls for Scaling up Global Action on Wetlands Conservation As COP14 OpensXi Urges Efforts to Carry Forward Great Founding Spirit of CPC and Yan'an SpiritChina Focus: Report to 20th CPC National Congress — How It Was ShapedXinhua Headlines: How the CPC's New Central Leadership Was FormedXi Meets S. Korean President Yoon SukChinese yuan strengthens to 7.0947 against USD Monday
2.9991s , 6499.7578125 kb
Copyright © 2024 Powered by FDA brings lab tests under federal oversight in bid to improve accuracy and safety ,Stellar Series news portal